Postoperative intravesical therapy to prevent bladder tumor recurrence: Are we ready to listen yet?

European Urology

Volumn 60, Issue 4, 2011, Pages 711-712

  Boorjian, Stephen A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

ABSENCE OF SIDE EFFECTS; BLADDER CANCER; BLADDER TUMOR; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER SURGERY; CHOLECYSTECTOMY; CLINICAL PROTOCOL; COST CONTROL; CYSTOSCOPY; CYTOLOGY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG UTILIZATION; EDITORIAL; EVIDENCE BASED MEDICINE; HEALTH CARE; HISTOPATHOLOGY; HUMAN; NEPHROURETERECTOMY; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK REDUCTION; SINGLE DRUG DOSE; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL BLADDER TUMOR RESECTION; TUMOR RECURRENCE; UPPER TRACT UROTHELIAL CARCINOMA;

ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MITOMYCIN; NEPHRECTOMY; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 80052258832     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.06.032     Document Type: Editorial

References (10)

1. T. O'Brien, E. Ray, R. Singh, B. Coker, and R. Beard Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C trial) Eur Urol 60 2011 703 710
2. J.D. Raman, C.K. Ng, S.A. Boorjian, E.D. Vaughan Jr., R.E. Sosa, and D.S. Scherr Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology BJU Int 96 2005 1031 1035 (Pubitemid 41531409)
3. W.J. Wu, H.L. Ke, Y.H. Yang, C.C. Li, Y.H. Chou, and C.H. Huang Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy? J Urol 183 2010 56 61
4. W. Oosterlinck, K.H. Kurth, F.H. Schröder, J. Bultinck, B. Hammond, and R. Sylvester A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder J Urol 149 1993 749 752 (Pubitemid 23111060)
5. R.J. Sylvester, W. Oosterlinck, and A.P. van der Meijden A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials J Urol 171 2004 2186 2190 (Pubitemid 38625431)
6. A. Feifer, X. Xie, J.M. Brophy, R. Segal, and W. Kassouf Contemporary cost analysis of single instillation of mitomycin after transurethral resection of bladder tumor in a universal health care system Urology 76 2010 652 657
7. M.C. Hall, S.S. Chang, and G. Dalbagni Guidelines for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update J Urol 178 2007 2314 2330 (Pubitemid 350080987)
8. M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Böhle, and J. Palou-Redorta EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder Eur Urol 54 2008 303 314
9. N.S. Clarke, S. Basu, S. Prescott, and R. Puri Chemo-prevention in superficial bladder cancer using mitomycin C: a survey of the practice patterns of British urologists BJU Int 97 2006 716 719 (Pubitemid 43383501)
10. R. Madeb, D. Golijanin, and K. Noyes Treatment of nonmuscle invading bladder cancer: do physicians in the US practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors Cancer 115 2009 2660 2670